Descriptor English: | Gatifloxacin | ||||||
Descriptor Spanish: |
Gatifloxacina
| ||||||
Descriptor Portuguese: | Gatifloxacina | ||||||
Descriptor French: | Gatifloxacine | ||||||
Entry term(s): |
1-cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid AM 1155 AM-1155 BMS 206584 BMS-206584 BMS206584 CG 5501 Gatifloxacine Tequin Zymar |
||||||
Tree number(s): |
D03.633.100.810.835.322.316 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077734 | ||||||
Scope note: | A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents Ophthalmic Solutions Topoisomerase II Inhibitors |
||||||
Registry Number: | L4618BD7KJ | ||||||
CAS Type 1 Name: | 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo- | ||||||
Public MeSH Note: | 2019; GATIFLOXACIN was indexed under FLUOROQUINOLONES 1992-2018 |
||||||
History Note: | 2019 (1992) |
||||||
DeCS ID: | 57739 | ||||||
Unique ID: | D000077734 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/10 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Gatifloxacin
- Preferred
Tequin
- Narrower
AM 1155
- Narrower
CG 5501
- Narrower
BMS-206584
- Narrower
Zymar
- Narrower
Concept UI |
M0209340 |
Scope note | A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS. |
Preferred term | Gatifloxacin |
Entry term(s) |
1-cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid Gatifloxacine |
Concept UI |
M0397728 |
Preferred term | Tequin |
Concept UI |
M0209341 |
Preferred term | AM 1155 |
Entry term(s) |
AM-1155 |
Concept UI |
M0209339 |
Preferred term | CG 5501 |
Concept UI |
M0209338 |
Preferred term | BMS-206584 |
Entry term(s) |
BMS 206584 BMS206584 |
Concept UI |
M0448581 |
Preferred term | Zymar |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey